Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Appl Microbiol Biotechnol ; 105(20): 7661-7681, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34568961

ABSTRACT

5'-Nucleotidases (EC 3.1.3.5) are enzymes that catalyze the hydrolytic dephosphorylation of 5'-ribonucleotides and 5'-deoxyribonucleotides to their respective nucleosides and phosphate. Most 5'-nucleotidases have broad substrate specificity and are multifunctional enzymes capable of cleaving phosphorus from not only mononucleotide phosphate molecules but also a variety of other phosphorylated metabolites. 5'-Nucleotidases are widely distributed throughout all kingdoms of life and found in different cellular locations. The well-studied vertebrate 5'-nucleotidases play an important role in cellular metabolism. These enzymes are involved in purine and pyrimidine salvage pathways, nucleic acid repair, cell-to-cell communication, signal transduction, control of the ribo- and deoxyribonucleotide pools, etc. Although the first evidence of microbial 5'-nucleotidases was obtained almost 60 years ago, active studies of genetic control and the functions of microbial 5'-nucleotidases started relatively recently. The present review summarizes the current knowledge about microbial 5'-nucleotidases with a focus on their diversity, cellular localizations, molecular structures, mechanisms of catalysis, physiological roles, and activity regulation and approaches to identify new 5'-nucleotidases. The possible applications of these enzymes in biotechnology are also discussed.Key points• Microbial 5'-nucleotidases differ in molecular structure, hydrolytic mechanism, and cellular localization.• 5'-Nucleotidases play important and multifaceted roles in microbial cells.• Microbial 5'-nucleotidases have wide range of practical applications.


Subject(s)
5'-Nucleotidase , Bacteria/enzymology , 5'-Nucleotidase/metabolism , Hydrolysis , Signal Transduction , Substrate Specificity
2.
Appl Microbiol Biotechnol ; 104(7): 2957-2972, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32040605

ABSTRACT

5'-Nucleotidases (EC 3.1.3.5) are enzymes that catalyze the hydrolytic dephosphorylation of 5'-ribonucleotides and 5'-deoxyribonucleotides to their corresponding nucleosides plus phosphate. In the present study, to search for new genes encoding 5'-nucleotidases specific for purine nucleotides in industrially important Bacillus species, "shotgun" cloning and the direct selection of recombinant clones grown in purine nucleosides at inhibitory concentrations were performed in the Escherichia coli GS72 strain, which is sensitive to these compounds. As a result, orthologous yitU genes from Bacillus subtilis and Bacillus amyloliquefaciens, whose products belong to the ubiquitous haloacid dehalogenase superfamily (HADSF), were selected and found to have a high sequence similarity of 87%. B. subtilis YitU was produced in E. coli as an N-terminal hexahistidine-tagged protein, purified and biochemically characterized as a soluble 5'-nucleotidase with broad substrate specificity with respect to various deoxyribo- and ribonucleoside monophosphates: dAMP, GMP, dGMP, CMP, AMP, XMP, IMP and 5-aminoimidazole-4-carboxamide-1-ß-D-ribofuranosyl 5'-monophosphate (AICAR-P). However, the preferred substrate for recombinant YitU was shown to be flavin mononucleotide (FMN). B. subtilis and B. amyloliquefaciens yitU overexpression increased riboflavin (RF) and 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) accumulation and can be applied to breed highly performing RF- and AICAR-producing strains.


Subject(s)
5'-Nucleotidase/metabolism , Bacillus/enzymology , Bacterial Proteins/metabolism , 5'-Nucleotidase/genetics , 5'-Nucleotidase/isolation & purification , Aminoimidazole Carboxamide/analogs & derivatives , Aminoimidazole Carboxamide/metabolism , Bacillus/drug effects , Bacillus/genetics , Bacillus amyloliquefaciens/drug effects , Bacillus amyloliquefaciens/enzymology , Bacillus amyloliquefaciens/genetics , Bacillus subtilis/drug effects , Bacillus subtilis/enzymology , Bacillus subtilis/genetics , Bacterial Proteins/genetics , Bacterial Proteins/isolation & purification , Cloning, Molecular , Escherichia coli/genetics , Escherichia coli/metabolism , Gene Expression , Kinetics , Purine Nucleotides/pharmacology , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Riboflavin/metabolism , Ribonucleosides/metabolism , Substrate Specificity
3.
J Microbiol Methods ; 148: 18-21, 2018 05.
Article in English | MEDLINE | ID: mdl-29596960

ABSTRACT

Bacillus subtilis pheS was genetically modified to obtain a counter-selection marker with high selection efficiency in Bacillus amyloliquefaciens. The application of the new replication-thermosensitive integrative vector pNZTM1, containing this marker, pheSBsT255S/A309G, with a two-step replacement recombination procedure provides an effective tool for the genetic engineering of industrially important Bacillus species.


Subject(s)
Bacillus amyloliquefaciens/genetics , Genetic Engineering/methods , Genetics, Microbial/methods , Selection, Genetic , Bacillus subtilis/enzymology , Bacillus subtilis/genetics , Phenylalanine-tRNA Ligase/genetics , Phenylalanine-tRNA Ligase/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Recombination, Genetic
4.
PLoS One ; 11(12): e0167580, 2016.
Article in English | MEDLINE | ID: mdl-27907199

ABSTRACT

5'-nucleotidases (EC 3.1.3.5) catalyze the hydrolytic dephosphorylation of 5'-ribonucleotides and 5'-deoxyribonucleotides as well as complex nucleotides, such as uridine 5'-diphosphoglucose (UDP-glucose), nicotinamide adenine dinucleotide and flavin adenine dinucleotide, to their corresponding nucleosides plus phosphate. These enzymes have been found in diverse species in intracellular and membrane-bound, surface-localized forms. Soluble forms of 5'-nucleotidases belong to the ubiquitous haloacid dehalogenase superfamily (HADSF) and have been shown to be involved in the regulation of nucleotide, nucleoside and nicotinamide adenine dinucleotide (NAD+) pools. Despite the important role of 5'-nucleotidases in cellular metabolism, only a few of these enzymes have been characterized in the Gram-positive bacterium Bacillus subtilis, the workhorse industrial microorganism included in the Food and Drug Administration's GRAS (generally regarded as safe) list. In the present study, we report the identification of a novel 5'-nucleotidase gene from B. subtilis, yutF, which comprises 771 bp encoding a 256-amino-acid protein belonging to the IIA subfamily of the HADSF. The gene product is responsible for the major p-nitrophenyl phosphatase activity in B. subtilis. The yutF gene was overexpressed in Escherichia coli, and its product fused to a polyhistidine tag was purified and biochemically characterized as a soluble 5'-nucleotidase with broad substrate specificity. The recombinant YutF protein was found to hydrolyze various purine and pyrimidine 5'-nucleotides, showing preference for 5'-nucleoside monophosphates and, specifically, 5'-XMP. Recombinant YutF also exhibited phosphohydrolase activity toward nucleotide precursors, ribose-5-phosphate and 5-phosphoribosyl-1-pyrophosphate. Determination of the kinetic parameters of the enzyme revealed a low substrate specificity (Km values in the mM concentration range) and modest catalytic efficiencies with respect to substrates. An initial study of the regulation of yutF expression showed that the yutF gene is a component of the yutDEF transcription unit and that YutF overproduction positively influences yutDEF expression.


Subject(s)
5'-Nucleotidase/biosynthesis , Bacillus subtilis/enzymology , Recombinant Proteins/biosynthesis , 5'-Nucleotidase/chemistry , 5'-Nucleotidase/genetics , Bacillus subtilis/chemistry , Bacillus subtilis/genetics , Escherichia coli/genetics , Gene Expression Regulation, Bacterial , Hydrolysis , Kinetics , Recombinant Proteins/genetics , Ribonucleotides/chemistry , Ribonucleotides/metabolism , Ribosemonophosphates/chemistry , Ribosemonophosphates/metabolism , Substrate Specificity
5.
Appl Microbiol Biotechnol ; 93(5): 2023-33, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22083279

ABSTRACT

Bacillus strains are used for the industrial production of the purine nucleosides inosine and guanosine, which are raw materials for the synthesis of the flavor enhancers disodium inosinate and disodium guanylate. An important precursor of purine nucleosides is 5-phospho-α-D: -ribosyl-1-pyrophosphate, which is synthesized by phosphoribosyl pyrophosphate synthetase (PRS, EC 2.7.6.1). Class I PRSs are widespread in bacteria and mammals, are highly conserved among different organisms, and are negatively regulated by two end products of purine biosynthesis, adenosine 5'-diphosphate (ADP) and guanosine 5'-diphosphate (GDP). The D52H, N114S, and L129I mutations in the human PRS isozyme I (PRS1) have been reported to cause uric acid overproduction and gout due to allosteric deregulation and enzyme superactivity. In this study, to find feedback-resistant Bacillus amyloliquefaciens PRS, the influence of the D58H, N120S, and L135I mutations (corresponding to the D52H, N114S, and L129I mutations in PRS1, respectively) on PRS enzymatic properties has been studied. Recombinant histidine-tagged wild-type PRS and three mutant PRSs were expressed in Escherichia coli, purified, and characterized. The N120S and L135I mutations were found to release the enzyme from ADP and GDP inhibition and significantly increase its sensitivity to inorganic phosphate (P(i)) activation. In contrast, PRS with the D58H mutation exhibited nearly identical sensitivity to ADP and GDP as the wild-type protein and had a notably greater P(i) requirement for activation. The N120S and L135I mutations improved B. amyloliquefaciens and Bacillus subtilis purine nucleoside-producing strains.


Subject(s)
Bacillus/enzymology , Guanosine/metabolism , Inosine/metabolism , Ribose-Phosphate Pyrophosphokinase/metabolism , Adenosine Diphosphate/metabolism , Amino Acid Substitution , Bacillus/genetics , Cloning, Molecular , Enzyme Inhibitors/metabolism , Escherichia coli/genetics , Gene Expression , Guanosine Diphosphate/metabolism , Molecular Sequence Data , Mutant Proteins/genetics , Mutant Proteins/metabolism , Mutation, Missense , Phosphoribosyl Pyrophosphate/metabolism , Ribose-Phosphate Pyrophosphokinase/genetics , Ribose-Phosphate Pyrophosphokinase/isolation & purification , Sequence Analysis, DNA
6.
J Ind Microbiol Biotechnol ; 38(1): 65-70, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20814730

ABSTRACT

Using a simple method to introduce genetic modifications into the chromosome of naturally nontransformable Bacillus, a set of marker-free inosine-producing and 5-aminoimidazole-4-carboxamide (AICA) ribonucleoside-producing Bacillus amyloliquefaciens strains has been constructed. These strains differ in expression levels of the genes responsible for nucleoside export. Overexpression of B. amyloliquefaciens pbuE and heterologous expression of Escherichia coli nepI, which encode nucleoside efflux transporters, each notably enhanced inosine production by a B. amyloliquefaciens nucleoside-producing strain. pbuE overexpression was found to increase AICA ribonucleoside accumulation, indicating that the substrate specificity of the PbuE pump extends to this nucleoside. These results demonstrate that identifying genes whose products facilitate transport of a desired nucleoside out of cells and enhancing their expression can improve the performance of strains used for industrial production.


Subject(s)
Bacillus/genetics , Bacterial Proteins/genetics , Genetic Engineering , Nucleoside Transport Proteins/genetics , Purine Nucleosides/metabolism , Aminoimidazole Carboxamide/analogs & derivatives , Bacillus/metabolism , Bacterial Proteins/metabolism , Escherichia coli/genetics , Female , Genes, Bacterial , Humans , Industrial Microbiology , Inosine/biosynthesis , Nucleoside Transport Proteins/metabolism , Ribonucleosides/biosynthesis , Transformation, Genetic
7.
Appl Microbiol Biotechnol ; 87(6): 2195-207, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20524113

ABSTRACT

In order to test a possible approach to enhance fermentative inosine production by Bacillus subtilis, seven gene-targeted mutations were introduced in the laboratory standard strain168 in a stepwise fashion. The mutations were employed in order to prevent inosine 5'-monophosphate (IMP) from being consumed for AMP and GMP synthesis, to minimize inosine degradation, and to expand the intracellular IMP pool. First, the genes for adenylosuccinate synthase (purA) and IMP dehydrogenase (guaB) were inactivated. Second, two genes for purine nucleoside phosphorylase, punA and deoD, were inactivated. Third, to enhance purine nucleotide biosynthesis, the pur operon repressor PurR and the 5'-UTR of the operon, containing the guanine riboswitch, were disrupted. Finally, the -10 sequence of the pur promoter was optimized to elevate its transcription level. The resulting mutant was capable of producing 6 g/L inosine from 30 g/L glucose in culture broth without the detectable by-production of hypoxanthine. This indicates the validity of this approach for the breeding of the next generation of B. subtilis strains for industrial nucleoside production.


Subject(s)
Bacillus subtilis/genetics , Bacillus subtilis/metabolism , Fermentation , Inosine/metabolism , Mutation , Adenylosuccinate Synthase/genetics , Adenylosuccinate Synthase/metabolism , Bacillus subtilis/enzymology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Gene Silencing , Gene Targeting , IMP Dehydrogenase/genetics , IMP Dehydrogenase/metabolism , Purine-Nucleoside Phosphorylase/genetics , Purine-Nucleoside Phosphorylase/metabolism
8.
Appl Microbiol Biotechnol ; 85(4): 1201-9, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19820923

ABSTRACT

A simple method to introduce marker-free deletions, insertions, and point mutations into the chromosomes of naturally nontransformable Bacillus amyloliquefaciens strains has been developed. The method is efficient and fast, and it allows for the generation of genetic modifications without the use of a counter-selectable marker or a special prerequisite strain. This method uses the combination of the following: the effective introduction of a delivery plasmid into cells for gene replacement; a two-step replacement recombination procedure, which occurs at a very high frequency due to the use of a thermosensitive rolling-circle replication plasmid; and colony polymerase chain reaction (PCR) analysis for screening. Using PCR primers with mismatches at the 3' end enables the selection of strains that contain a single nucleotide substitution in the target gene. This approach can be used as a routine method for the investigation of complex physiological pathways and for the metabolic engineering of food-grade industrial B. amyloliquefaciens and other Bacillus strains.


Subject(s)
Bacillus/genetics , Chromosomes, Bacterial , Mutagenesis , Transformation, Bacterial , Bacillus/metabolism , Bacterial Proteins/genetics , DNA, Bacterial/genetics , Escherichia coli/genetics , Gene Deletion , Genes, Bacterial , Genetic Markers , Genetic Vectors , Glucose 1-Dehydrogenase/genetics , Membrane Proteins/genetics , Mutagenesis, Insertional , Mutagenesis, Site-Directed , Point Mutation , Promoter Regions, Genetic , Regulatory Sequences, Nucleic Acid
9.
Res Microbiol ; 158(8-9): 659-65, 2007.
Article in English | MEDLINE | ID: mdl-17935948

ABSTRACT

The pbuE (ydhL) gene from Bacillus subtilis is known to encode the purine base efflux pump, and its expression is controlled by an adenine-dependent riboswitch. We cloned the pbuE gene from Bacillus amyloliquefaciens and examined gene expression by its own cis-acting regulatory elements in Escherichia coli. Regulation of pbuE expression, previously found in B. subtilis, was retained in this heterologous expression: it was induced by adenine and activated by a mutation in the 5' untranslated region, which disrupted transcription termination. This observation supports the model that the adenine-dependent riboswitch directly regulates pbuE expression, without requiring additional factors. Overexpression of the PbuE pump conferred upon the E. coli strain resistance to higher concentrations of inosine, adenosine and guanosine, and increased exogenous inosine accumulation by E. coli cells deficient in purine nucleoside phosphorylase. Overexpression of the PbuE pump also enhanced hypoxanthine excretion by the E. coli hypoxanthine-producing strain and inosine excretion both by the E. coli and B. amyloliquefaciens nucleoside-producing strains. Thus, for the first time, we obtained direct evidence for the involvement of PbuE in efflux of not only purine bases, but also purine ribonucleosides. A possible new role for the pump in cell physiology is discussed.


Subject(s)
Bacillus subtilis/metabolism , Bacterial Proteins/physiology , Purine Nucleosides/metabolism , Purines/metabolism , Bacterial Proteins/genetics , Cloning, Molecular , Escherichia coli/genetics , Escherichia coli/growth & development , Purine-Nucleoside Phosphorylase/physiology
10.
FEBS Lett ; 579(21): 4629-34, 2005 Aug 29.
Article in English | MEDLINE | ID: mdl-16098526

ABSTRACT

Overexpression of the yeaS gene encoding a protein belonging to the RhtB transporter family conferred upon cells resistance to glycyl-l-leucine, leucine analogues, several amino acids and their analogues. yeaS overexpression promoted leucine and, to a lesser extent, methionine and histidine accumulation by the respective producing strains. Our results indicate that yeaS encodes an exporter of leucine and some other structurally unrelated amino acids. The expression of yeaS (renamed leuE for "leucine export") was induced by leucine, l-alpha-amino-n-butyric acid and, to a lesser extent, by several other amino acids. The global regulator Lrp mediated this induction.


Subject(s)
Amino Acid Transport Systems, Neutral/metabolism , Escherichia coli Proteins/metabolism , Escherichia coli/genetics , Gene Expression Regulation, Bacterial , Leucine/metabolism , Membrane Transport Proteins/metabolism , Amino Acid Transport Systems, Neutral/genetics , Base Sequence , DNA-Binding Proteins , Escherichia coli/metabolism , Escherichia coli Proteins/genetics , Histidine/metabolism , Leucine/chemistry , Leucine-Responsive Regulatory Protein , Membrane Proteins/genetics , Membrane Proteins/metabolism , Membrane Transport Proteins/genetics , Methionine/metabolism , Transcription Factors , Transcription Initiation Site
11.
FEMS Microbiol Lett ; 250(1): 39-47, 2005 Sep 01.
Article in English | MEDLINE | ID: mdl-16040204

ABSTRACT

The yicM gene of Escherichia coli was found by selection for resistance to 6-mercaptopurine. Translation and transcription initiation sites of yicM were determined. Overexpression of yicM increased resistance of sensitive cells to inosine and guanosine, decreased E. coli growth rate in medium containing these ribonucleosides as the sole carbon source, led to inosine accumulation by the E. coli strain deficient in purine nucleoside phosphorylase and enhanced the rate of inosine excretion by an inosine-producing strain. These results suggest that yicM encodes a purine ribonucleoside exporter and we have accordingly renamed it nepI (for 'nucleoside efflux permease-inosine').


Subject(s)
Escherichia coli Proteins/genetics , Escherichia coli Proteins/metabolism , Escherichia coli/genetics , Escherichia coli/metabolism , Genes, Bacterial , Nucleotide Transport Proteins/genetics , Nucleotide Transport Proteins/metabolism , Purine Nucleosides/metabolism , Ribonucleosides/metabolism , Base Sequence , Biological Transport, Active , Cloning, Molecular , Culture Media , DNA, Bacterial/genetics , Drug Resistance, Bacterial/genetics , Escherichia coli/drug effects , Escherichia coli/growth & development , Gene Expression , Inosine/metabolism , Mercaptopurine/pharmacology , Molecular Sequence Data , Protein Biosynthesis , Purine Nucleosides/pharmacology , Purine-Nucleoside Phosphorylase/metabolism , Ribonucleosides/pharmacology , Transcription, Genetic
12.
Res Microbiol ; 154(2): 123-35, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12648727

ABSTRACT

The rhtA gene known as the ybiF ORF in the genome of Escherichia coli was identified as a new gene involved in threonine and homoserine efflux. This gene encodes a highly hydrophobic membrane protein that contains 10 predicted transmembrane segments. The rhtA23 mutation, which is an A-for-G substitution at position -1 in relation to the ATG start codon, increases the expression level of the rhtA gene. The overexpression of rhtA gene results in resistance to inhibitory concentrations of homoserine, threonine and a variety of other amino acids and amino acid analogues, reduced threonine and homoserine accumulation in resistant cells and increased production of threonine, homoserine, lysine and proline by the respective producing strains. The RhtA protein belongs to a vast family of transporters. The genome of E. coli contains at least 10 paralogues of RhtA. Phylogenetic analysis indicates that a common ancestor of living organisms contained several RhtA homologues.


Subject(s)
Escherichia coli Proteins/metabolism , Escherichia coli/metabolism , Homoserine/metabolism , Membrane Proteins/chemistry , Membrane Proteins/metabolism , Threonine/metabolism , Amino Acid Sequence , Amino Acid Substitution , Amino Acids/metabolism , Amino Acids/pharmacology , Base Sequence , Escherichia coli/drug effects , Escherichia coli/genetics , Escherichia coli Proteins/chemistry , Escherichia coli Proteins/genetics , Membrane Proteins/genetics , Microbial Sensitivity Tests , Molecular Sequence Data , Phylogeny , Sequence Analysis, Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...